Pure Global
NCT06047574

Multidisciplinary Diagnosis and Treatment of Polycystic Ovary Syndrome

Multidisciplinary Combined Precise Diagnosis and Treatment of Polycystic Ovary Syndrome
Shanghai 10th People's Hospital·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Polycystic Ovary Syndrome
Drug/Device/Intervention
This study does not involve any interventions
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
Shanghai 10th People's Hospital
Location
Shanghai, China
Timeline & enrollment
Phase
N/A
Start date
Sep 18, 2023
End date
Jul 30, 2025
Enrollment
3000 participants
Primary outcome

Fibrinogen-like-protein 1 (FGL1)

Summary

The investigators collected clinical data and serum samples of patients with polycystic ovary
 syndrome (PCOS) in this study, used statistical software such as SPSS for date analysis, and
 used experimental techniques such as ELISA and flow cytometry to detect serum samples, aiming
 to explore the relationship between the body anthropometry, skin conditions, psychosomatic
 status, diet, sleep, exercise, glucose and lipid metabolism, gonadal hormones, and body fat
 distribution in patients with polycystic ovary syndrome, and to discovery new biomarkers.
 Multidisciplinary exploration of the mechanisms of disease occurrence and development, the
 establishment of a PCOS multicenter, multidisciplinary and multidimensional clinical research
 database, combined with the established statistical analysis strategy for big data and
 analysis, to promote the realization of more accurate personalized medicine.

ICD-10 classifications
Polycystic ovarian syndromeOvarian dysfunction, unspecifiedOvarian dysfunctionOther ovarian dysfunctionNeoplasm of uncertain or unknown behaviour: Ovary
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06047574
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06047574 through Pure Global AI's free database. This phase not specified trial is sponsored by Shanghai 10th People's Hospital and is currently Recruiting. The study focuses on Polycystic Ovary Syndrome. Target enrollment is 3000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.